3.05
price down icon1.61%   -0.05
after-market After Hours: 3.17 0.12 +3.93%
loading
Stereotaxis Inc stock is traded at $3.05, with a volume of 286.09K. It is down -1.61% in the last 24 hours and up +8.54% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$3.10
Open:
$3.11
24h Volume:
286.09K
Relative Volume:
0.50
Market Cap:
$277.77M
Revenue:
$25.14M
Net Income/Loss:
$-21.57M
P/E Ratio:
-11.30
EPS:
-0.27
Net Cash Flow:
$-12.23M
1W Performance:
+0.00%
1M Performance:
+8.54%
6M Performance:
+67.58%
1Y Performance:
+55.61%
1-Day Range:
Value
$3.01
$3.11
1-Week Range:
Value
$2.935
$3.204
52-Week Range:
Value
$1.54
$3.59

Stereotaxis Inc Stock (STXS) Company Profile

Name
Name
Stereotaxis Inc
Name
Phone
314-678-6100
Name
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Name
Employee
118
Name
Twitter
@stereotaxis
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
STXS's Discussions on Twitter

Compare STXS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
STXS
Stereotaxis Inc
3.05 282.31M 25.14M -21.57M -12.23M -0.27
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
462.74 164.35B 9.15B 2.63B 1.99B 7.1661
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
189.03 54.75B 21.39B 1.61B 2.55B 5.5609
Medical Instruments & Supplies icon
RMD
Resmed Inc
268.22 39.61B 5.15B 1.40B 1.65B 9.5082
Medical Instruments & Supplies icon
ALC
Alcon Inc
75.76 37.31B 10.03B 1.07B 1.39B 2.1549
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
279.39 19.77B 2.96B 487.70M 344.00M 6.6758

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-10-24 Initiated ROTH MKM Buy
Jul-12-22 Initiated Aegis Capital Buy
Jun-23-22 Initiated B. Riley Securities Buy
Jan-05-22 Initiated Craig Hallum Buy
Jan-05-22 Initiated Loop Capital Buy
May-26-21 Initiated Piper Sandler Overweight
Sep-08-20 Initiated Northland Capital Outperform
Apr-09-20 Initiated Cowen Outperform
Apr-07-20 Initiated Lake Street Buy
View All

Stereotaxis Inc Stock (STXS) Latest News

pulisher
Oct 21, 2025

Visualizing Stereotaxis Inc. stock with heatmaps2025 Big Picture & AI Powered Trade Plan Recommendations - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Published on: 2025-10-21 19:22:31 - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Automated trading signals detected on Stereotaxis Inc.July 2025 EndofMonth & Accurate Entry and Exit Point Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Can Stereotaxis Inc. stock resist broad market declinesInflation Watch & Verified Technical Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Can Stereotaxis Inc. stock retain market dominanceEarnings Beat & Weekly Watchlist of Top Performers - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Stereotaxis (NYSE: STXS) sets Q3 2025 results call and webcast information - Stock Titan

Oct 21, 2025
pulisher
Oct 21, 2025

What valuation ratios show for Stereotaxis Inc. stockQuarterly Trade Review & Risk Controlled Daily Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval - sharewise.com

Oct 21, 2025
pulisher
Oct 20, 2025

Can Stereotaxis Inc. stock test all time highsForecast Cut & Free Technical Pattern Based Buy Signals - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Will Stereotaxis Inc. stock outperform tech sector in 20252025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com

Oct 20, 2025
pulisher
Oct 18, 2025

Is Stereotaxis Inc. stock attractive for income investorsJuly 2025 Short Interest & AI Based Buy and Sell Signals - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Is Stereotaxis Inc. stock a buy in volatile marketsJuly 2025 Intraday Action & Low Drawdown Trading Strategies - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Stereotaxis Inc. stock a buy on dips2025 Geopolitical Influence & Free Long-Term Investment Growth Plans - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 16, 2025

Stereotaxis Synchrony System Gets European CE Mark; Applies for FDA 510(k) Certification - Diagnostic and Interventional Cardiology

Oct 16, 2025
pulisher
Oct 16, 2025

Is Stereotaxis Inc. stock trading near support levelsMarket Activity Summary & Technical Pattern Based Buy Signals - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Can Stereotaxis Inc. stock continue upward trendMarket Risk Analysis & Growth Oriented Trade Recommendations - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Stereotaxis Earns EU Nod for Synchrony System, Submits to FDA - Medical Product Outsourcing

Oct 15, 2025
pulisher
Oct 15, 2025

How Stereotaxis Inc. stock stacks up against competitors2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Stereotaxis teams with CardioFocus to develop robotic PFA system - MedTech Dive

Oct 15, 2025
pulisher
Oct 15, 2025

Stereotaxis Obtains CE Mark in Europe, Files Application to FDA for Synchrony System - MarketScreener

Oct 15, 2025
pulisher
Oct 15, 2025

Stereotaxis (STXS) Moves Forward with Synchrony System Approvals - GuruFocus

Oct 15, 2025
pulisher
Oct 15, 2025

Stereotaxis obtains CE mark for Synchrony system, files FDA application By Investing.com - Investing.com Canada

Oct 15, 2025
pulisher
Oct 15, 2025

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs - GlobeNewswire

Oct 15, 2025
pulisher
Oct 15, 2025

CE Mark & 510(k) Submission: Stereotaxis Launches Synchrony with 55” 4K Display and SynX Cloud - Stock Titan

Oct 15, 2025
pulisher
Oct 15, 2025

Order flow analysis tools used on Stereotaxis Inc.Earnings Recap Summary & Daily Stock Momentum Reports - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

STXS Partners With CardioFocus to Boost Robotic Pulsed Field Ablation - sharewise.com

Oct 14, 2025
pulisher
Oct 13, 2025

Stereotaxis, CardioFocus Collab to Advance Robotic Pulsed Field Ablation - Medical Product Outsourcing

Oct 13, 2025
pulisher
Oct 13, 2025

Stereotaxis (STXS) Partners with CardioFocus to Develop Robotic PFA Technology - GuruFocus

Oct 13, 2025
pulisher
Oct 13, 2025

Stereotaxis and CardioFocus partner to develop robotic PFA technology - Investing.com

Oct 13, 2025
pulisher
Oct 13, 2025

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias - GlobeNewswire

Oct 13, 2025
pulisher
Oct 12, 2025

Is Stereotaxis Inc. stock trading at attractive multiplesWeekly Profit Summary & Real-Time Buy Signal Alerts - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Stereotaxis Inc Stock Analysis and ForecastInstitutional Holding Changes & Free Explosive Portfolio Gains - earlytimes.in

Oct 10, 2025
pulisher
Oct 09, 2025

Stereotaxis, Inc. Hits New 52-Week High of $3.58, Marking Key Milestone - Markets Mojo

Oct 09, 2025

Stereotaxis Inc Stock (STXS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$15.60
price up icon 2.77%
medical_instruments_supplies BAX
$22.75
price down icon 1.64%
$72.91
price up icon 0.05%
medical_instruments_supplies COO
$75.00
price up icon 0.01%
$73.98
price up icon 2.94%
medical_instruments_supplies WST
$279.39
price up icon 1.63%
Cap:     |  Volume (24h):